 |
|
 |
 |

Home > Company Index > Drugs > Diagnostic Substances > GMP Companies, Inc.
 |
GMP Companies, Inc. |
 |
 |
 |
PROFILE |
 |
GMP Companies, through about a dozen subsidiaries, acquires and develops pharmaceuticals, diagnostic products, and medical devices. The development-stage firm has bought or licensed about 20 product candidates from universities, medical schools, and other research entities that typically lack the capital or expertise to bring their technologies to market. Its first product, GMP Conversion Technology (acquired from Johns Hopkins University), is designed to improve the accuracy of genetic testing. GMP is also working on treatments for diabetes, glaucoma, and spinal cord injuries, as well as drug delivery systems and coronary stents. Investors in GMP include Quest Diagnostics, Medtronic, and Motorola.
COMPETITION |
 |
Advanced Neuromodulation Systems, Inc. (ANSI)
BioMedicines, Inc. (dossier)
Radiance Medical Systems, Inc. (RADX)
|
 |
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
1999 Sales (mil.): 0.00
Employees: 100
Revenue per employee: $0.00
KEY PEOPLE |
 |
Bart Chernow
CEO
Holger Weis
CFO
CONTACT INFO |
 |
1 E. Broward Blvd., Ste. 1701
Fort Lauderdale, FL 33301
US
Phone: 954-745-3510
Fax: 954-745-3511
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |